Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

Clinical research institutions, universities and academic medical centers, pharmaceutical companies, medical device manufacturers, and other health and life sciences industry organizations are focused on protecting and leveraging their investments in research, development and innovation. We provide critical counseling to help preserve your assets, mitigate regulatory risk and get your products to market as expediently as possible. From clinical trials and product design to premarket approval and product launch, our team of attorneys and other professionals guides you in carefully crafting clinical trial, licensing, research and development, and other agreements; obtaining appropriate patents or other intellectual property protection; obtaining FDA and other regulatory approvals; addressing reimbursement strategies; and preparing for product liability defenses. We help you take advantage of federal tax exemptions, strategically change clinical trial processes or product designs, and conduct evidence-based advocacy to enhance federal support for areas of distinction. We are recognized for our work with clients in the areas of orphan drugs, patient-focused drug development, pediatrics and Alzheimer’s disease, among many others, and work with you to develop and win approval of treatments and medications that address some of today’s most pressing, unmet needs. We have the experience to help bring innovation to the industry and, most importantly, to patients.

Insights & Events

Insights
Updates February 2025

A Deeper Dive Into the Making America Healthy Again Commission’s Executive Order and Its Implications

While Some Elements Lie Within the Mainstream, Others Are Cause for Concern
5 min read  
Media Mentions February 2025

Tricia Beckmann Discusses Federal Oversight of Medicare Brokers With Law360

1 min read  
Media Mentions February 2025

Doriann Cain Provides Insight in Navigating HIPAA Compliance With Becker’s Hospital Review

1 min read  
Media Mentions January 2025

Libby Baney Discusses Future of Remote Prescription Regulation Under New Administration With Modern Healthcare

1 min read  
Podcast November 2024

Libby Baney Discusses Dangers of Illegal Online Pharmacies on the Weekly Dose Podcast

1 min read  
Updates September 2024

New Investment Opportunity in China’s Health Care Sector Following Recent Legal Reforms

3 min read  
Media Mentions September 2024

Libby Baney Comments on Regulation Options for the Online Sales of Steroid Trenbolone in Men’s Health

1 min read  
Published Articles December 2023

DEA Updates: Three New Rules Every Pharmacist Should Know

1 min read  
Published Articles August 2023

Ilse Peterson and Fatou Sarr Highlight COVID-19 Impacts on Neuromuscular Disease Community and Views Toward Telemedicine

1 min read  
Published Articles January 2023

Meeting Report: The ALPHA Project — A Stakeholder Meeting on Lupus Clinical Trial Outcome Measures and the Patient Perspective

1 min read  

Related Legal Services